BridgeMD
New treatment option for Opioid Use Disorder
Official title Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
ClinicalTrials.gov ID: NCT07158853
What this study is testing
- What it's testing
- The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Ability to provide consent and comply with study procedures
- Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
- Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
- Intention to remain in the study until intervention completion.
You likely can't join if
- Any medical condition with neurological sequelae
- Head injury resulting in skull fracture or loss of consciousness of \>30 minutes
- Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates/screws or implanted device, history of eczema on scalp. MRI...
- Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)
- Presence of a condition that would render study measures impossible to administer or interpret
- Age younger than 18
See the full eligibility criteria
- Ability to provide consent and comply with study procedures
- Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
- Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
- Intention to remain in the study until intervention completion.
- Any medical condition with neurological sequelae
- Head injury resulting in skull fracture or loss of consciousness of \>30 minutes
- Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates/screws or implanted device, history of eczema on scalp. MRI: unapproved metallic implants, pacemakers or any other implanted...
- Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)
- Presence of a condition that would render study measures impossible to administer or interpret
- Age younger than 18
- Primary current substance use disorder on a substance other than opioids except for caffeine or nicotine
- In treatment instead of jail
- Pregnancy
- Disrespectful behavior towards the investigators and staff.
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.